$\"\"$ <\/a>

Laboratory Safety<\/p><\/div>\n

BOOKS<\/em><\/strong>:<\/p>\n

\u00d6ryggishandb\u00f3k ranns\u00f3knarstofunnar<\/strong> [Handbook of Laboratory Safety]. 184 pages. H\u00e1sk\u00f3la\u00fatg\u00e1fan, Reykjavik 2010 (link to each chapter<\/a>)<\/li>\n<\/ol>\n
REVIEW ARTICLES:<\/em><\/strong><\/p>\n
\n
Guo, S., Beleites, C., Neugebauer, U., Abalde-Cela, S., Afseth, N.K., Alsamad, F., Anand, S., Araujo-Andrade, C., A\u0161krabi\u0107, S., Avci, E., Baia, M., Baranska, M., Baria, E., Carvalho, L.A.E.B., Bettignies, P., Bonifacio, A., Bonnier, F., Brauchle, E.M., Byrne, H.J., Chourpa, I., Cicchi, R., Cuisinier, F., Culha, M., Dahms, M., David, C., Duponchel, L., Duraipandian, S., El-Mashtoly, S.F., Ellis, D.I., Eppe, G., Falgayrac, G., Gamulin, O., Gardner, B., Gardner, P., Gerwert, K., Giamarellos-Bourboulis, E.J., Gizurarson, S., Gnyba, M., Goodacre,R., Grysan, P., Guntinas-Lichius, O., Helgadottir, H., Gro\u0161ev, V.M., Kendall, C., Kiselev, R., K\u00f6lbach, M., Krafft, C., Krishnamoorthy, C., Kubryck, P., Lendl, B., Loza-Alvarez, P., Lyng, F.M., Machill, S., Malherbe, C., Marro, M., Marques, M.P.M., Matuszyk, E., Morasso, C.F., Moreau, M., Muhamadali, H., Mussi, V., Notingher, I., Pacia, M.Z., Pavone, F.S., Penel, G., Petersen, D., Piot, O., Rau, J.V., Richter, M., Rybarczyk, M.K., Salehi, H., Schenke-Layland, K., Schl\u00fccker, S., Schosserer, M., Sch\u00fctze, K., Sergo, V., Sinjab, F., Smulko, J., Sockalingum, G., Stiebing, C., Stone, N., Untereiner, v., Vanna, R., Wieland, K., Popp, J:, Bocklitz, T. Comparability of Raman Spectroscopic Configurations: A Large Scale Cross-Laboratory Study. Analytical Chemistry<\/em> (in press)<\/li>\n
Sammar M, Drobnjak T, Mandala M, Gizurarson S, Huppertz B, Meiri H. Galectin 13 (PP13) facilitates remodeling and structural stabilization of maternal vessels during pregnancy. Int. J. Molecular Sci<\/em>. 20, 3192 (17p), 2019<\/li>\n
Schijns V, Fern\u00e1ndez-Tejada A, Barjaktarovi\u0107 \u017d, Bouzalas I, Brimnes J, Chernysh S, Gizurarson S, Gursel I, Jakopin \u017d, Lawrenz M, Nativi C, Paul S, Pedersen GK, Rosano C, Ruiz-de-Angulo A, Sl\u00fctter B, Thakur A, Christensen D, Lavelle EC. Modulation of immune responses using adjuvants to facilitate therapeutic vaccination. Immunological Reviews<\/em> 296, 169-190 (22p), 2020<\/li>\n
Erd\u0151 F, Bors LA, Farkas D, Bajza \u00c1, Gizurarson S. Evaluation of intranasal delivery route of drug administration for CNS indication (Invited article). Brain Research Bulletin<\/em>, 143, 155-170, 2018<\/li>\n
Meiri H, Osol G, Cetin I, Gizurarson S, Huppertz B. Personalized Therapy Against Preeclampsia by Replenishing Placental Protein 13 (PP13) Targeted to Patients with Impaired PP13 Molecule or Function. Computational and Structural Biotechnology Journal<\/em>, 15, 433-446, 2017<\/li>\n
Gizurarson S: The Effect of Cilia and the Mucociliary Clearance on Successful Drug Delivery. Biol. Pharm. Bull<\/em>. 38 (4), 497-506, 2015<\/li>\n
Than GN, Balogh A, Romero R, K\u00e1rp\u00e1ti \u00c9, Erez O, Szil\u00e1gyi A, Kovalszky I, Sammar M, Gizurarson S, Matk\u00f3 J, Z\u00e1vodszky P, Papp Z, Meiri H. Placental protein 13 (PP13) - a placental immunoregulatory galectin protecting pregnancy. Frontiers in Immunology<\/em> 5<\/strong> (Article 348), 1-25, 2014 \u00a0(Link<\/a>)<\/li>\n
Huppertz B, Meiri H, Gizurarson S, Osol G, Sammar M. Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia. Human Reproduction Update<\/em> 19<\/strong> (4), 391-405, 2013 (Link<\/a>)<\/li>\n
Bj\u00f6rnsd\u00f3ttir US, Gizurarson S, Sabale U. Potential negative consequences of non-consented switch of inhaled medications and devices in asthma patients. Int J Clin Pract.<\/em> 57<\/strong> (9) 904-910, 2013 (Link<\/a>)<\/li>\n
Gizurarson S.\u00a0Anatomical and histological factors affecting intranasal drug and vaccine delivery.\u00a0Current drug delivery<\/em> 9<\/strong> (6), 566-582, 2012 (Link<\/a>)<\/li>\n
Gizurarson S.\u00a0History of Intranasal Delivery and the Nose.\u00a0Pharmaceutical Historian<\/em> 41<\/strong> (4), 66-72, 2011<\/li>\n
S. Gizurarson: Clinically relevant vaccine-vaccine interactions: a guide for practitioners. BioDrugs 9, 443-453, 1998<\/em> (Invited contribution)<\/li>\n
S. Gizurarson: Optimal delivery of vaccines. Clinical pharmacokinetical considerations.\u00a0Clin. Pharmacokin.<\/em> 30<\/strong>, 1-16, 1996 (Invited contribution)<\/li>\n
S. Gizurarson: The relevance of nasal physiology to the design of drug absorption studies.\u00a0Advanced Drug Deliv. Rev.<\/em> 11<\/strong>, 329-347, 1993 (Invited contribution)<\/li>\n
S. Gizurarson:\u00a0In situ<\/em> method to estimate local effect of nasal preparations.\u00a0Scand. J. Lab. Anim. Sci.<\/em> 19<\/strong>, 129-135, 1992<\/li>\n
S. Gizurarson & E. Bechgaard: Intranasal application of insulin to humans.\u00a0Diab. Res. Clin. Pract.<\/em> 12<\/strong>, 71-84, 1991 (link<\/a>)<\/li>\n
S. Gizurarson: Animal models for intranasal drug delivery studies.\u00a0Acta Pharm. Nord.<\/em> 2<\/strong>, 105-122, 1990<\/li>\n<\/ol>\n
ARTICLES<\/em><\/strong><\/p>\n
\n
Patlolla VGR, Holbrook WP, Gizurarson S, Kristmundsdottir \u00de. Long-term stabilization of aqueous doxycycline formulations, in mucoadhesive hydrogels for treatment of oral mucosal conditions. Curr. Drug Discov. Technol.<\/em> 17, 376-386, 2020<\/li>\n
Helgad\u00f3ttir H, Lund SH, Gizurarson S, Metz DC, Bj\u00f6rnsson ES. Predictors of Gastrin Elevation Following Proton Pump Inhibitor Therapy. J. Clin Gastroenterol<\/em>. 54, 227-234 (8p), 2020<\/li>\n
Helgadottir H, Tropea T, Gizurarson S, Meiri H, Mandala M. Vasodilatation of aspirin on resistant arteries from non-gravid vs. gravid rats. Pregnancy Hypertension, 15, 141-145, 2019
\n90. Drobnjak T, J\u00f3nsd\u00f3ttir AM, Helgad\u00f3ttir H, Run\u00f3lfsd\u00f3ttir MS, Meiri H, Mandal\u00e1 M, Huppertz B, Gizurarson S. Placental Protein 13 (PP13) stimulates rat uterine vessels after slow subcutaneous administration. Int. J. Womens Health<\/em>, 11, 213-22, 2019<\/li>\n
Patlolla VGR, Holbrook WP, Gizurarson S, Kristmundsdottir \u00de. Doxycycline and Monocaprin In Situ Hydrogel: Effect on Stability, Mucoadhesion and Texture Analysis and In Vitro Release. Gels<\/em>, 5, 47 (13p), 2019<\/li>\n
Helgad\u00f3ttir H, Lund SH, Bj\u00f6rnsson E, Gizurarson S, Waldum H. Serum concentration and pharmacokinetics of single and repeated oral doses of esomeprazole and gastrin elevation in healthy males and females. Gastroenterology AGA<\/em>, 156, S308, 2019<\/li>\n
Patlolla VGR, Holbrook WP, Gizurarson S, Kristmundsdottir \u00de. Evaluation of in vitro mucoadhesiveness and texture profile analysis of doxycycline in situ hydrogels. Pharmazie<\/em> 74, 9122 (6p), 2019<\/li>\n
Helgad\u00f3ttir H, \u00d3lafsson \u00cd, Andersen K, Gizurarson S. Stability of thromboxane in blood samples. Vascular Health Risk Management<\/em>, 15, 143-147, 2019<\/li>\n
Drobnjak T, Meiri H, Mandala M, Huppertz B, Gizurarson S. Pharmacokinetics of placental protein 13 after intravenous and subcutaneous administration in rabbits. Drug Design Develop. Therapy<\/em> 12, 1977\u20131983, 2018<\/li>\n
Helgad\u00f3ttir H , Metz DC , Lund SH , Gizurarson S , Jacobsen EI , Asgeirsd\u00f3ttir GA , Yngad\u00f3ttir Y, Bj\u00f6rnsson ES. Study of Gender Differences in Proton Pump Inhibitor Dose Requirements for GERD: A Double-Blind Randomized Trial. Journal of Clinical Gastroenterology<\/em> 51 (6), 486-493, 2017<\/li>\n
Hada N, Netzer WJ, Belhassan F, Wennogle LP, Gizurarson S. Nose-to-Brain Transport of Imatinib Mesylate: A Pharmacokinetic Evaluation. (Project supported by Dr. Paul Greengard, Nobel Prize Laureate). Eur J Pharm Sci<\/em> 102, 46\u201354, 2017<\/li>\n
Drobnjak T, Gizurarson S, Gokina NI, Meiri H, Mandala M, Huppertz B, Osol G. The vasodilatory effect of placental protein 13 (PP13) in pregnant and non-pregnant rat resistance arteries is endothelial-signalled via nitric oxide synthase and cyclooxygenase pathways. Hypertension in Pregnancy<\/em> 36 (2), 186-195, 2017<\/li>\n
Gizurarson S, Helgad\u00f3ttir EL, \u00d3lafsd\u00f3ttir S, \u00d3lafsson DR, Sigur\u00f0ard\u00f3ttir, Hautala A, Ylihonka K. Heliomycin: Evaluation of its in vivo pharmacokinetics in rats. Int J Res Pharm Biosci<\/em> 4 (2), 1-6, 2017<\/li>\n
Bl\u00f6ndal AB, Almarsdottir AB, Jonsson JS, Gizurarson S. Pharmaceutical care at the primary care clinic in Gardabaer - number and type of drug therapy problems identified among elderly clients. Laeknabla\u00f0i\u00f0<\/em> 103, 481-486, 2017<\/li>\n
Rolnik DL, Wright D, Poon LC, O\u2019Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Persico N, Jani JC, Plasencia W, Papaioannou G, Tenenbaum\u2011Gavish K, Meiri H, Gizurarson S, Maclagan K, Nicolaides KH. Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia. New England Journal of Medicine (NEJM)<\/em>, 377 (7), 613-622, 2017<\/li>\n
Rolnik D, Wright D, Poon LC, O'Gorman N, Syngelaki A, de Paco Matallana C, Akolekar R, Cicero S, Janga D, Singh M, Molina FS, Perisco N, Jani JC, Plasencia W, Papaioannou G, Tennebaum Gavish K, Meiri H, Gizurarson S, Nicolaides KH. Aspirin versus placebo in pregnancies at high-risk of preterm pre-eclampsia: a multicentre, double-blind, placebo-controlled trial. Ultrasound Obstetrics Gynecology<\/em>, 50 (S1), 2, 2017<\/li>\n
Nielsen BO, Gunnlaugsson SV, Gizurarson S. Oxandrolone Case Study. Sport Medicine and Rehabilitation Journal<\/em> 2 (3) 1023 (1-2), 2017<\/li>\n
Volmer D, Sokirskaja A, Laaksonen R, Vainio K, Sandler N, Halvorsen KH, Kjome R, Gizurarson S, Muceniece R, Maurina B, Dauksiene J, Ruuben L, Bj\u00f6rnsdottir I, Hein\u00e4m\u00e4ki J. Medical technology education for pharmacy students and practicing pharmacists in the Nordic and Baltic countries. Pharmacy<\/em> 4, 29, 2016<\/li>\n
Gizurarson S, Meiri H, Huppertz B, Sammar M, Osol G. Placental protein 13 (PP13) shows beneficial effects on the maternal vasculature in pregnant rats: potential benefits in preeclampsia and IUGR. Placenta<\/em> 35<\/strong> (9), A85-A85, 2014 (Link<\/a>)<\/li>\n
Sammar M, Huppertz B, Gizurarson S, Meiri H, Osol G. Placental protein 13: Characterization of a naturally occurring variant lacking the carbohydrate recognition domain. Placenta<\/em> 35<\/strong> (9), A84-A84, 2014 (Link<\/a>)<\/li>\n
Sammar M, Nisamblatt S, Gonen R, Huppertz B, Gizurarson S, Osol G, Meiri H. The role of the carbohydrate recognition domain of placental protein 13 (PP13) in pregnancy evaluated with recombinant PP13 and the DelT221 PP13 variant. PloS one<\/em> 9<\/strong> (7) e102932, 2014 (Link<\/a>)<\/li>\n
Bj\u00f6rnsd\u00f3ttir US, Sigur\u00f0ard\u00f3ttir ST, Jonsson JS, J\u00f3nsson M, Telg G, Thuresson M, Naya I, Gizurarson S. Impact of changes to reimbursement of fixed combinations of inhaled corticosteroids and long-acting beta2-agonists in obstructive lung diseases: a population -based, observation study. Int. J Clin Practice<\/em> 68<\/strong> (7) 812-819, 2014 (Link<\/a>)<\/li>\n
L\u00e4hde A, Gu\u00f0mundsd\u00f3ttir SS, Joutsensaari J, Tapper U,\u00a0Ruusunen J, Ihalainen M, Karhunen T, Torvela T, Jokiniemi J, J\u00e4rvinen K, G\u00edslason SR, Briem H, Gizurarson S. In vitro evaluation of pulmonary deposition of airborne volcanic ash. Atmospheric Environment 70, 18-27, 2013 (Link<\/a>)<\/li>\n
Fungfuang W, Nakada T, Nakao N, Terada M, Yokosuka M, Gizurarson S, Hau J, Moon C, Saito TR. Serum leptin concentrations, leptin mRNA expression, and food intake during the estrous cycle in rats. Lab Anim Res<\/em> 29<\/strong> (1) 1-6, 2013 (Link<\/a>)<\/li>\n
Gizurarson S, Huppertz B, Osol G, Skarph\u00e9\u00f0insson J\u00d3, Mandal\u00e1 M, Meiri H. Effects of placental protein 13 on the cardiovascular system in gravid and non-gravid rodents.\u00a0Fetal diagnosis and therapy<\/em>\u00a0<\/span>33<\/strong> (<\/span>4)\u00a0257-264, 2013 (Link<\/a>)<\/span><\/span><\/li>\n
Sigur\u00f0ard\u00f3ttir S, J\u00f3nsson JS, Naya I, Telg G, J\u00f3nsson M, Thuresson M, Gizurarson S, Bj\u00f6rnsd\u00f3ttir US.\u00a0Clinical Impacts Of Reimbursement Changes For Fixed Ics\/laba Combination Therapy In Well-Controlled Asthma And COPD Patients In Iceland.\u00a0Am J Respir Crit Care Med.<\/em>\u00a0187<\/strong>, A5225, 2013 (Link<\/a>)<\/li>\n
Almarsdottir AB, Karlsdottir \u00c1D, Gu\u00f0mundsson A, Halld\u00f3rsson M, Gizurarson S.\u00a0Did the Fall of the Icelandic Banks Affect Psychotropic Drug Use in the Population?\u00a0Pharmacoepidemiology and Drug Safety<\/em> 20<\/strong>, S87-S88, 2011<\/li>\n
Yokusaka M, Takagi S, Katou M, Pudcharaporn K, Gizurarson S, Ichikawa M, SaitoTR. p<\/em>-chloroamphetamine-induced rat ejaculation is not associated with the preoptic nucleus or medial nucleus amygdale. Reprod. Med. Biol.<\/em> 7<\/strong>, 37-43, 2008.<\/li>\n
Hrafnkelsdottir K, Valgeirsson J, Bjarnadottir S, \u00d3lafsdottir S, \u00d3lafsdottir K, H\u00e9\u00f0insd\u00f3ttir ST, Magnusdottir EV, Gizurarson S. Immunization prevents DDT build-up in mouse tissues. Int. Immunopharm.<\/em> 7<\/strong>, 1179-1184, 2007<\/li>\n
Freysdottir J, Hardardottir I, Gizurarson S, Vikingsson A. Mucosal tolerance to KLH reduces BSA-induced arthritis in rats \u2013 an indication of bystander suppression. J. Clin. Immunol.<\/em> 27<\/strong> (3) 284-293, 2007<\/li>\n
Gizurarson S, Bechgaard E, Hjortkj\u00e6r RK. Two intranasal administration techniques give two different pharmacokinetic results. Scand. J. Lab. Animal Sci.<\/em> 33<\/strong> (1) 35-38, 2006<\/li>\n
Freysdottir J, Hardardottir I, Gizurarson S, Vikingsson A. Mucosal tolerance to KLH reduces BSA-induced arthritis in rats \u2013 an indication of bystander suppression. Scand J Rheum<\/em> 35<\/strong> (suppl 121), 22, 2006.<\/li>\n
Freysdottir J, Bogason ET, Gizurarson S, Vikingsson A. Influence of passive cigarette smoke on joint swelling and on mucosal tolerance induction. Scand J Rheum<\/em> 35<\/strong> (suppl 121), 44-45, 2006.<\/li>\n
Mayo SL, Tufvesson M, Carlsson HE, Royo F, Gizurarson S, Hau J. RhinoVax \u00ae is an efficient adjuvant in oral immunisation of young chickens and cholera toxin B is an effective oral primer in subcutaneous immunisation with Freund's incomplete adjuvant. In Vivo<\/em> 19<\/strong> (2): 375-382, 2005<\/li>\n
Hrafnkelsdottir K, Valgeirsson J, Gizurarson S. Induction of protective and specific antibodies against cocaine by intranasal immunisation using a glyceride adjuvant. Biol. Pharm. Bull.<\/em> 28<\/strong> (6): 1038-1042, 2005<\/li>\n
Freysdottir J, Hardardottir I, Gizurarson S, Vikingsson A Mucosal tolerance to KLH reduces BSA-induced arthritis in rats? an indication of bystander suppression. Immunology<\/em> 116<\/strong> (Suppl. 1): 45, 2005<\/li>\n
Gissurarson LR, Karlsson GM, Gizurarson S, Hrafnkelsdottir K, Sigurdardottir K, Ofeigsson BG. Improving unbiased left\/right training of rats and use of physostigmine to counteract scopolamine-induced short-term memory impairment \u00a0Scand. J. Lab. Animal Sci.<\/em> 31<\/strong> (2): 101-112, 2004<\/li>\n
Lindhardt K, Olafsson DR, Gizurarson S, Bechgaard E. Intranasal bioavailability of diazepam in sheep correlated to rabbit and man. Int. J. Pharm<\/em>. 231<\/strong> (1): 67-72, 2002<\/li>\n
Gizurarson S: Published referee on work carried out by: Born J, Lange T, Kern W, McGregor GP, Bickel U, Fehm HL; Sniffing neuropeptides a transnasal approach to the human brain. Nature Neuroscience<\/em> 5<\/strong>: 514-516, 2002<\/li>\n
Lindhardt K, Gizurarson S, Stefansson SB, Olafsson DR, Bechgaard E: Electroencephalographic effects and serum concentrations after intranasal and intravenous administration of diazepam to healthy volunteers. Br. J. Clin. Pharmacol<\/em>. 52<\/strong> (5): 521-527, 2001<\/li>\n
Horvath A, Andersen I, Junker K, Fogh-Schultz BL, Nielsen EH, Gizurarson S, Andersen O, Karman J, Rajjavolgyi E, Erdei A, Svehag SE: Serum amyloid P component inhibits influenza A virus infections: in vitro and in vivo studies. Antiviral Res<\/em>. 52<\/strong> (1): 43-53, 2001<\/li>\n
Lindhardt K, Ravn C, Gizurarson S and Bechgaard E. Intranasal absorption of buprenorphine \u2013 in vivo bioabailability study in sheep. Int. J. Pharm<\/em>. 205, 159-163, 2000<\/li>\n
Olafsson DR and\u00a0Gizurarson S. Access to the olfactory region. Proceedings Controlled Release of Bioactive Materials<\/em>. 27<\/strong>: #6318, 2000<\/li>\n
S. Gizurarson, F.K. Gudbrandsson, H. J\u00f3nsson and E. Bechgaard. Intranasal administration of diazepam \u2013 aiming at the treatment of acute seizures. Biol. Pharm. Bull. <\/em>22, (4) 1-3, 1999<\/li>\n
R.K. Hjortkj\u00e6r, E. Bechgaard, S. Gizurarson, C. Suzdak and B. Guldhammer. Acute and long term toxicity in the nasal cavity, after administration of benzodiazepines formulated in various glycerols, to rabbits. J. Pharm. Pharmacol.<\/em> 51, 1-8, 1999<\/li>\n
H. Jakobsen, E. S\u00e6land, S. Gizurarson, D. Schulz and I. J\u00f3nsd\u00f3ttir. Intranasal immunization with pneumococcal polysaccharide conjugate vaccines protects mice against invasive pneumococcal infections. Infection & Immunity <\/em>67, 4128-4133, 1999<\/li>\n
S. Gizurarson, M. Sigurdard\u00f3ttir & B. Stanzeit. Intranasal and subcutaneous administration of diphtheria toxoid. The kinetics of homing to different organs. J.Pharm. Sci .<\/em>87, 1267-1269, 1998 (link<\/a>)<\/li>\n
S. Gizurarson, H. Aggerbeck, M.R. Gudmundsson and I. Heron. Intranasal vaccination: Pharmaceutical evaluation of the vaccine delivery system and immunokinetic characteristics of the immune response. Pharm. Develop. Techn.<\/em> 3, 385-394, 1998<\/li>\n
S. Gizurarson, H. Aggerbech, F.K. Gudbrandsson, H. Valdemarsson and I. Heron. Intranasal vaccination against diphtheria and tetanus in human subjects. Vaccine Res.<\/em> 6<\/strong>, 41-47, 1997<\/li>\n
S. Gizurarson, T. Thorvaldsson, P. Sigurdsson and E. Gunnarsson. Selective delivery of insulin into the brain. Intraolfactorial absorption. Int. J. Pharm.<\/em> 147, 135-141, 1997<\/li>\n
H. Aggerbeck, S. Gizurarson, J. Wantzin and I. Heron. Intranasal booster vaccination against diphtheria and tetanus in man. Vaccine<\/em> 15, 307-316, 1997.<\/li>\n
E. Bechgaard, S. Gizurarson and R.K. Hjortkj\u00e6r. Pharmacokinetic and pharmacodynamic response after intranasal administration of diazepam to rabbits. J. Pharm. & Pharmacol<\/em> 49<\/strong>, 747-750, 1997<\/li>\n
E. Bechgaard, S. Gizurarson and R.K. Hjortkj\u00e6r. Solubilization of various benzodiazepines for intranasal administration. Pharm. Develop. Techn<\/em>. 2<\/strong>, 293-296, 1997<\/li>\n
P. Sigurdsson, T. Thorvaldsson and S. Gizurarson. Olfactory absorption of insulin to the brain. Mechanisms of action. Drug Delivery<\/em> 4, 195-200, 1997<\/li>\n
S. Gizurarson, H. Aggerbeck and I. Heron. Intranasal vaccination. Clinical trials in humans. Mucosal Immunol. Updates<\/em> 4, 33, 1996<\/li>\n
E. Bechgaard, S. Gizurarson, R.K. Hjort\u00adkj\u00e6r & A.R. S\u00f8rensen. Intranasal administration of insulin to rabbits using glycofurol as an absorption enhancer Int. J. Pharm.<\/em> 128<\/strong>, 287-289, 1996<\/li>\n
S. Gizurarson, G. Georgsson, H. Aggerbeck, H. Thorarinsd\u00f3ttir & I. Heron. Evaluation of\u00a0 local toxicity after repeated intranasal vaccination of guinea pigs. Toxicology<\/em> 107<\/strong>, 61-68, 1996<\/li>\n
S. Gizurarson, H. Aggerbeck, S.G. \u00c1rnad\u00f3ttir, C.H. Mordhorst and I. Heron. Intranasal vaccination against influenza, using pharmaceutical excipients as immunological adjuvants. Vaccine Res.<\/em> 5<\/strong>, 69-75, 1996<\/li>\n
S. Gizurarson, T. Thorvaldsson, P. Sigurdsson and E. Gunnarsson. Selective delivery of insulin into the brain. Intraolfactorial absorption. Int. J. Pharm.<\/em> 140, 77-83, 1996<\/li>\n
S. Gizurarson, V. M. J\u00f3nsd\u00f3ttir & I. Heron. Intranasal administration of diphtheria toxoid. Selecting antibody isotypes using formulations having various lipophilic characteristics. Vaccine<\/em> 13<\/strong>, 617-621, 1995<\/li>\n
S. Gizurarson, P. Sigurdsson, T. Thorvaldsson & E. Gunnarsson. Technique for administering drugs to the brain and bypassing the blood-brain-barrier. Scand. J. Lab. Anim. Sci.<\/em> 22<\/strong>, 273-276, 1995<\/li>\n
S. Gizurarson, T. Kurata, C. Aizawa & S. Tamura. Pharmaceutical excipients and absorption promoters as additional immunostimulants to a mucosal adjuvant (cholera toxin B subunit). Vaccine Res<\/em>. 3<\/strong>, 23-29, 1994<\/li>\n
S. Gizurarson & H. Thorarinsdottir. Local chemical irritation on mucosal surfaces, measured colorimetrically on the frog palate model. Scand. J. Lab. Anim. Sci.<\/em> 21<\/strong>, 123-126, 1994<\/li>\n
E. Bechgaard, L. J\u00f8rgensen, R. Larsen, S. Gizurarson, J. Carstensen & A. Hvass: Insulin and dodecanoyl-L-a-phosphati\u00addylcholine: in vitro study of the transport through rabbit nasal mucosal tissue. Int. J. Pharm.<\/em> 89<\/strong>, 147-153, 1993<\/li>\n
S. Gizurarson, S. Tamura, C. Aizawa & T. Kurata: Stimulation of the transepi\u00adthel\u00adial flux of influenza HA vaccine by cholera toxin B subunit. Vaccine<\/em> 10<\/strong>, 101-106, 1992<\/li>\n
E. Bechgaard, S. Gizurarson, L. J\u00f8rgensen & R. Larsen: The viability of isolated rabbit nasal mucosa in the ussing chamber and the permeability of insulin across the membrane. Int. J. Pharm.<\/em> 87<\/strong>, 125-132, 1992<\/li>\n
S. Gizurarson, S. Tamura, T. Kurata, K. Hashiguchi & H. Ogawa: The effect of cholera toxin and cholera toxin B subunit on the nasal mucosal membrane. Vaccine<\/em> 9<\/strong>, 825-832, 1991<\/li>\n
S. Gizurarson, S.N. Rasmussen & F. Larsen: Pharmacokinetics of intranasal drug administration. The influence of some biological factors. J. Pharm. Sci.<\/em> 80<\/strong>, 505-506, 1991 (link<\/a>)<\/li>\n
S. Gizurarson & E. Bechgaard: Insulin-carrying microspher\u00ades. In vitro<\/em> study. Chem. Pharm. Bull.<\/em> 39<\/strong>, 1892-1893, 1991<\/li>\n
S. Gizurarson & E. Bechgaard: In vitro <\/em>study of nasal enzyme activity towards insulin. Chem. Pharm. Bull.<\/em> 39<\/strong>, 2155-2157, 1991<\/li>\n
S. Gizurarson, S. Tamura & T. Kurata: Estimating tissue permeability and other bioelectrical parameters using membrane votage and short-circuit current. Chem. Pharm. Bull.<\/em> 39<\/strong>, 1636-1637, 1991<\/li>\n
S. Gizurarson, C. Marriott, G.P. Martin & E. Bechgaard: The influence of insulin and some excipients used in nasal insulin preparations on the mucociliary clearance. Int. J. Pharm.<\/em> 65<\/strong>, 243-247, 1990 (link<\/a>)<\/li>\n
S. Gizurarson: A simple flow injection method for the determination of blood glucose using Technicon immobilized enzyme coil. J. Autom. Chem.<\/em> 11<\/strong>, 87-88, 1989 (link<\/a>)<\/li>\n
S. Gizurarson, A. Jensen & S. Foss: A simple flow injection analysis for the studies of drug-protein binding interactions in serum. Acta Pharm. Nord.<\/em> 1<\/strong>, 291-294, 1989 (link<\/a>)<\/li>\n
S. Gizurarson: Activated carbon for the removal of the ointment base before kinetic assay of nitroglycerin ointment. Fresenius. Z. Anal. Chem.<\/em> 322<\/strong>, 177-178, 1988 (link<\/a>)<\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"
BOOKS: \u00d6ryggishandb\u00f3k ranns\u00f3knarstofunnar [Handbook of Laboratory Safety]. 184 pages. H\u00e1sk\u00f3la\u00fatg\u00e1fan, Reykjavik 2010 (link to each chapter) REVIEW ARTICLES: Guo, S., Beleites, C., Neugebauer, U., Abalde-Cela, S., Afseth, N.K., Alsamad, F., Anand, S., Araujo-Andrade, C., A\u0161krabi\u0107, S., Avci, E., Baia, M., Baranska, M., Baria, E., Carvalho, L.A.E.B., Bettignies, P., Bonifacio, A., Bonnier, F., Brauchle, E.M., Byrne, […]<\/p>\n","protected":false},"author":333,"featured_media":0,"parent":0,"menu_order":5,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-12","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/uni.hi.is\/sveinbj\/wp-json\/wp\/v2\/pages\/12","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/uni.hi.is\/sveinbj\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/uni.hi.is\/sveinbj\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/uni.hi.is\/sveinbj\/wp-json\/wp\/v2\/users\/333"}],"replies":[{"embeddable":true,"href":"https:\/\/uni.hi.is\/sveinbj\/wp-json\/wp\/v2\/comments?post=12"}],"version-history":[{"count":20,"href":"https:\/\/uni.hi.is\/sveinbj\/wp-json\/wp\/v2\/pages\/12\/revisions"}],"predecessor-version":[{"id":168,"href":"https:\/\/uni.hi.is\/sveinbj\/wp-json\/wp\/v2\/pages\/12\/revisions\/168"}],"wp:attachment":[{"href":"https:\/\/uni.hi.is\/sveinbj\/wp-json\/wp\/v2\/media?parent=12"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}